Assessment of ventilation heterogeneity in severe asthma using phase‐resolved functional lung magnetic resonance imaging

Assessment of ventilation heterogeneity in severe asthma using phase‐resolved functional lung magnetic resonance imaging

Abstract Ventilation heterogeneity is a hallmark of asthma. This study examines the feasibility of phase‐resolved functional lung magnetic resonance imaging (PREFUL MRI) in the evaluation of ventilation heterogeneity in severe asthma, its response to bronchodilator, and correlation with spirometry....

Full description

Saved in:
Bibliographic Details
Main Authors: Chuan T. Foo, David Langton, Graham M. Donovan, Bruce R. Thompson, Peter B. Noble, Francis Thien
Format: Article
Language:English
Published: Wiley 2025-06-01
Series:Physiological Reports
Subjects:
asthma
functional lung imaging
lung physiology
magnetic resonance imaging
ventilation heterogeneity
Online Access:https://doi.org/10.14814/phy2.70423
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Ventilation heterogeneity is a hallmark of asthma. This study examines the feasibility of phase‐resolved functional lung magnetic resonance imaging (PREFUL MRI) in the evaluation of ventilation heterogeneity in severe asthma, its response to bronchodilator, and correlation with spirometry. Twenty‐three patients with severe asthma and seven healthy volunteers completed PREFUL MRI and spirometry pre and post‐bronchodilator. Ventilation heterogeneity was assessed using ventilation defect percentages (VDP) for regional ventilation (RVent) and flow‐volume loop cross‐correlation (FVL), interquartile distance (IQD), and inhomogeneity index (IHI). Patients exhibited a significantly higher pre‐bronchodilator VDPRVent (19.9 ± 14.0 vs. 1.9 ± 1.9%, p < 0.001), VDPFVL (21.6 ± 15.9 vs. 1.7 ± 2.1%, p < 0.001), IQD (0.60 ± 0.25 vs. 0.30 ± 0.06, p < 0.001), and IHI (0.34 ± 0.12 vs. 0.18 ± 0.04, p < 0.001) compared to healthy volunteers. Post‐bronchodilator, VDPRVent (14.7 ± 12.5 vs. 19.9 ± 14.0%, p = 0.02), IQD (0.51 ± 0.20 vs. 0.60 ± 0.25, p = 0.02), and IHI (0.30 ± 0.11 vs. 0.34 ± 0.12, p = 0.02) decreased significantly in patients but remained significantly higher than in healthy volunteers. Significant correlations were observed between pre‐bronchodilator FEV1 and VDPRVent (ρ = −0.61, p < 0.001), VDPFVL (ρ = −0.73, p < 0.001), IQD (ρ = −0.57, p = <0.001), and IHI (ρ = −0.60, p < 0.001). PREFUL MRI derived markers of ventilation heterogeneity are worse in patients with asthma, improve post‐bronchodilator, and correlate with the severity of airflow obstruction. These findings support the role of PREFUL MRI in assessing ventilation heterogeneity in asthma.
ISSN:2051-817X

Similar Items